Authors:
BOOIJ J
ANDRINGA G
RIJKS LJM
VERMEULEN RJ
DEBRUIN K
BOER GJ
JANSSEN AGM
VANROYEN EA
Citation: J. Booij et al., [I-123] FP-CIT BINDS TO THE DOPAMINE TRANSPORTER AS ASSESSED BY BIODISTRIBUTION STUDIES IN RATS AND SPECT STUDIES IN MPTP-LESIONED MONKEYS, Synapse, 27(3), 1997, pp. 183-190
Authors:
STOOF JC
VERMEULEN RJ
VANROYEN EA
DRUKARCH B
VOORN P
WOLTERS EC
GROENEWEGEN HJ
Citation: Jc. Stoof et al., DOPAMINERGIC SYSTEMS AND PARKINSONS-DISEASE - SOME LATEST DEVELOPMENTS IN PATHOGENETIC, DIAGNOSTIC AND PHARMACOTHERAPEUTIC INVESTIGATIONS, Neuroscience research communications, 18(3), 1996, pp. 133-142
Authors:
RIJKS LJ
BOOIJ J
DOORNBOS T
BOER GJ
RONKEN E
DEBRUIN K
VERMEULEN RJ
JANSSEN AGM
VANROYEN EA
Citation: Lj. Rijks et al., IN-VITRO AND IN-VIVO CHARACTERIZATION OF NEWLY DEVELOPED IODINATED 1-(2-[BIS(4-FLUOROPHENYL)METHOXY]ETHYL) PIPERAZINE DERIVATIVES IN RATS -LIMITED VALUE AS DOPAMINE TRANSPORTER SPECT LIGANDS, Synapse, 23(3), 1996, pp. 201-207
Authors:
VERMEULEN RJ
DRUKARCH B
SAHADAT MCR
GOOSEN C
SCHOFFELMEER ANM
WOLTERS EC
STOOF JC
Citation: Rj. Vermeulen et al., MORPHINE AND NALTREXONE MODULATE D-2 BUT NOT D-1 RECEPTOR-INDUCED MOTOR BEHAVIOR IN MPTP-LESIONED MONKEYS, Psychopharmacology, 118(4), 1995, pp. 451-459
Authors:
VERMEULEN RJ
WOLTERS RC
TISSINGH G
BOOIJ J
JANSSEN AGM
HABRAKEN J
SOKOLEBUSEMANN E
STOOF JC
VANROYEN EA
Citation: Rj. Vermeulen et al., EVALUATION OF [I-123] BETA-CIT BINDING WITH SPECT IN CONTROLS, EARLY AND LATE PARKINSONS-DISEASE, Nuclear medicine and biology, 22(8), 1995, pp. 985-991
Citation: Ea. Dubois et al., IMAGING AND QUANTIFICATION OF MUSCARINIC RECEPTORS IN THE HUMAN HEARTAND BRAIN IN-VIVO, British Journal of Pharmacology, 114, 1995, pp. 142-142
Citation: Rj. Vermeulen et al., DOPAMINE D-1 RECEPTOR AGONISTS DISPLAY A DIFFERENT INTRINSIC ACTIVITYIN RAT, MONKEY AND HUMAN ASTROCYTES, European journal of pharmacology. Molecular pharmacology section, 269(1), 1994, pp. 121-125
Authors:
VERMEULEN RJ
DRUKARCH B
VERHOEFF NPLG
GOOSEN C
SAHADAT MCR
WOLTERS EC
VANROYEN EA
STOOF JC
Citation: Rj. Vermeulen et al., NO DIRECT CORRELATION BETWEEN BEHAVIORALLY ACTIVE DOSES OF THE DOPAMINE D-2 AGONIST LY-171555 AND DISPLACEMENT OF [I-123] IBZM AS MEASURED WITH SPECT IN MPTP MONKEYS, Synapse, 17(2), 1994, pp. 115-124
Authors:
VERMEULEN RJ
DRUKARCH B
SAHADAT MCR
GOOSEN C
WOLTERS EC
STOOF JC
Citation: Rj. Vermeulen et al., THE DOPAMINE-D-1 AGONIST SKF-81297 AND THE DOPAMINE-D-2 AGONIST LY-171555 ACT SYNERGISTICALLY TO STIMULATE MOTOR BEHAVIOR OF ETHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE-LESIONED PARKINSONIAN RHESUS-MONKEYS, Movement disorders, 9(6), 1994, pp. 664-672
Authors:
VERMEULEN RJ
DRUKARCH B
SAHADAT MCR
GOOSEN C
WOLTERS EC
STOOF JC
Citation: Rj. Vermeulen et al., THE DOPAMINE-D-1 AGONIST SKF-81297 AND THE DOPAMINE-D-2 AGONIST LY-171555 ACT SYNERGISTICALLY TO STIMULATE MOTOR BEHAVIOR OF ETHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE-LESIONED PARKINSONIAN RHESUS-MONKEYS, Movement disorders, 9(6), 1994, pp. 664-672
Authors:
VERMEULEN RJ
DRUKARCH B
SAHADAT MCR
GOOSEN C
WOLTERS EC
STOOF JC
Citation: Rj. Vermeulen et al., THE SELECTIVE DOPAMINE-D(1) RECEPTOR AGONIST, SKF-81297, STIMULATES MOTOR BEHAVIOR OF MPTP-LESIONED MONKEYS, European journal of pharmacology, 235(1), 1993, pp. 143-147